Sit Investment Associates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1M Sell
20,197
-4,643
-19% -$3.09M 0.31% 78
2026
Q1
$13.5M Sell
24,840
-7,575
-23% -$3.09M 0.27% 92
2025
Q4
$10.2M Hold
32,415
0.2% 124
2025
Q3
$8.75M Buy
32,415
+6,300
+24% +$1.44M 0.18% 139
2025
Q2
$5.76M Sell
26,115
-3,210
-11% -$578K 0.12% 180
2025
Q1
$3.85M Hold
29,325
0.09% 232
2024
Q4
$4.02M Buy
29,325
+300
+1% +$41.2K 0.09% 233
2024
Q3
$2.94M Buy
+29,025
New +$2.3M 0.07% 268

Other funds holding AGX

Sit Investment Associates's AGX Position: Q2 2026 in Review

Sit Investment Associates reduced its Argan (AGX) stake by 19% in Q2 2026, selling an estimated $3.09M and leaving 20,197 shares worth $16.1M. The position accounts for 0.31% of the portfolio, ranked #78.

Sit Investment Associates first reported a position in AGX in Q3 2024 and has held it in 8 quarters since. 563 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Sit Investment Associates held 20,197 shares of Argan worth $16.1M as of Q2 2026.
  • Sit Investment Associates sold 4,643 Argan shares in Q2 2026, an estimated $3.09M.
  • Argan made up 0.31% of Sit Investment Associates's portfolio in Q2 2026, its #78 holding.
  • Sit Investment Associates first reported a position in Argan in Q3 2024 and has held it in 8 quarters since.
  • 563 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.